PLMR Q1 2026 Earnings Earnings Beat Driven by Underwriting Strength China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment Envela Corporation ELA Q1 2026 Earnings Massive EPS Surprise of 2285 Drives Investor Interest SRBK Q3 2025 Earnings Narrow Profit Reported as Stock Declines Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations SMMT Q1 2026 Earnings EPS Misses Estimates as Development Costs Mount